Raymond James Financial Services Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $21.2M | Sell |
252,749
-14,974
| -6% | -$1.14M | 0.03% | 528 |
|
|
2024
Q2 | $18.4M | Sell |
267,723
-64,635
| -19% | -$4.31M | 0.03% | 546 |
|
|
2024
Q1 | $24.3M | Buy |
332,358
+36,037
| +12% | +$2.77M | 0.04% | 438 |
|
|
2023
Q4 | $24M | Buy |
296,321
+45,272
| +18% | +$3.52M | 0.04% | 420 |
|
|
2023
Q3 | $18.8M | Sell |
251,049
-18,436
| -7% | -$1.42M | 0.03% | 472 |
|
|
2023
Q2 | $20.8M | Sell |
269,485
-25,114
| -9% | -$2M | 0.04% | 455 |
|
|
2023
Q1 | $24.4M | Buy |
294,599
+47,644
| +19% | +$3.95M | 0.05% | 379 |
|
|
2022
Q4 | $21.2M | Sell |
246,955
-24,948
| -9% | -$1.98M | 0.04% | 413 |
|
|
2022
Q3 | $16.8M | Buy |
271,903
+7,917
| +3% | +$499K | 0.04% | 434 |
|
|
2022
Q2 | $16.3M | Sell |
263,986
-29,424
| -10% | -$1.82M | 0.04% | 459 |
|
|
2022
Q1 | $17.4M | Buy |
293,410
+43,788
| +18% | +$2.8M | 0.03% | 487 |
|
|
2021
Q4 | $18.1M | Sell |
249,622
-43,946
| -15% | -$3.03M | 0.03% | 483 |
|
|
2021
Q3 | $20.5M | Sell |
293,568
-20,760
| -7% | -$1.46M | 0.04% | 437 |
|
|
2021
Q2 | $21.6M | Buy |
314,328
+31,699
| +11% | +$2.12M | 0.04% | 416 |
|
|
2021
Q1 | $18.3M | Sell |
282,629
-4,355
| -2% | -$281K | 0.04% | 427 |
|
|
2020
Q4 | $16.7M | Sell |
286,984
-40,353
| -12% | -$2.43M | 0.04% | 410 |
|
|
2020
Q3 | $20.7M | Sell |
327,337
-81,981
| -20% | -$5.69M | 0.06% | 312 |
|
|
2020
Q2 | $31.5M | Sell |
409,318
-57,118
| -12% | -$4.38M | 0.1% | 213 |
|
|
2020
Q1 | $34.9M | Buy |
466,436
+121,117
| +35% | +$8.37M | 0.15% | 140 |
|
|
2019
Q4 | $22.4M | Buy |
345,319
+32,405
| +10% | +$2.11M | 0.07% | 279 |
|
|
2019
Q3 | $19.8M | Buy |
312,914
+62,845
| +25% | +$4.11M | 0.07% | 288 |
|
|
2019
Q2 | $16.9M | Sell |
250,069
-10,245
| -4% | -$674K | 0.06% | 323 |
|
|
2019
Q1 | $16.9M | Sell |
260,314
-4,542
| -2% | -$302K | 0.07% | 307 |
|
|
2018
Q4 | $16.6M | Buy |
264,856
+1,711
| +0.7% | +$120K | 0.09% | 252 |
|
|
2018
Q3 | $20.3M | Buy |
263,145
+40,087
| +18% | +$3.03M | 0.09% | 250 |
|
|
2018
Q2 | $15.8M | Sell |
223,058
-79,816
| -26% | -$5.64M | 0.08% | 281 |
|
|
2018
Q1 | $22.8M | Buy |
302,874
+15,459
| +5% | +$1.23M | 0.13% | 170 |
|
|
2017
Q4 | $20.6M | Buy |
287,415
+4,022
| +1% | +$305K | 0.13% | 176 |
|
|
2017
Q3 | $23M | Sell |
283,393
-4,942
| -2% | -$378K | 0.15% | 153 |
|
|
2017
Q2 | $20.4M | Buy |
288,335
+38,044
| +15% | +$2.53M | 0.14% | 162 |
|
|
2017
Q1 | $17M | Sell |
250,291
-26,773
| -10% | -$1.88M | 0.13% | 187 |
|
|
2016
Q4 | $19.8M | Sell |
277,064
-20,076
| -7% | -$1.49M | 0.17% | 138 |
|
|
2016
Q3 | $23.5M | Buy |
297,140
+27,273
| +10% | +$2.22M | 0.21% | 116 |
|
|
2016
Q2 | $22.5M | Sell |
269,867
-13,758
| -5% | -$1.22M | 0.22% | 113 |
|
|
2016
Q1 | $26.1M | Buy |
283,625
+9,123
| +3% | +$823K | 0.3% | 74 |
|
|
2015
Q4 | $27.8M | Buy |
274,502
+30,234
| +12% | +$3.15M | 0.33% | 69 |
|
|
2015
Q3 | $24M | Buy |
244,268
+139,266
| +133% | +$15.5M | 0.4% | 51 |
|
|
2015
Q2 | $12.3M | Buy |
+105,002
| New | +$11.5M | 0.88% | 18 |
|
|
2014
Q3 | – | Sell |
-13,126
| Closed | -$1.09M | – | 554 |
|
|
2014
Q2 | $1.09M | Sell |
13,126
-213
| -2% | -$16.6K | 0.06% | 314 |
|
|
2014
Q1 | $945K | Buy |
13,339
+276
| +2% | +$21.6K | 0.06% | 340 |
|
|
2013
Q4 | $981K | Sell |
13,063
-2,300
| -15% | -$160K | 0.06% | 316 |
|
|
2013
Q3 | $966K | Sell |
15,363
-63,441
| -81% | -$3.79M | 0.06% | 311 |
|
|
2013
Q2 | $4.04M | Buy |
+78,804
| New | +$4.11M | 0.12% | 203 |
|
Other funds holding GILD
Raymond James Financial Services Advisors's GILD Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its Gilead Sciences (GILD) stake by 5.6% in Q3 2024, selling an estimated $1.14M and leaving 252,749 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #528.
Raymond James Financial Services Advisors first reported a position in GILD in Q2 2013 and has held it in 43 quarters since. The position peaked at $34.9M in Q1 2020. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- Raymond James Financial Services Advisors held 252,749 shares of Gilead Sciences worth $21.2M as of Q3 2024.
- Raymond James Financial Services Advisors sold 14,974 Gilead Sciences shares in Q3 2024, an estimated $1.14M.
- Gilead Sciences made up 0.03% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #528 holding.
- Raymond James Financial Services Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 43 quarters since.
- Raymond James Financial Services Advisors's Gilead Sciences position peaked at $34.9M in Q1 2020.
- 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.